“Our measurements provide crucial information for human missions to Mars,” said Dr. Don Hassler, a Southwest Research Institute program director and RAD principal investigator. Hassler is the lead author of “Mars’ Surface Radiation Environment Measured with the Mars Science Laboratory’s Curiosity Rover,” scheduled for publication in the journal Science online on December 9, 2013.
“We’re continuing to monitor the radiation environment, and seeing the effects of major solar storms on the surface and at different times in the solar cycle will give additional important data. Our measurements also tie into Curiosity’s investigations about habitability. The radiation sources that are of concern for human health also affect microbial survival as well as the preservation of organic chemicals.”
Two forms of radiation pose potential health risks to astronauts: a chronic low dose of galactic cosmic rays (GCRs) and the possibility of short-term exposures to the solar energetic particles (SEPs) associated with solar flares and coronal mass ejections. The radiation on Mars is much harsher than on Earth for two reasons: Mars lacks a global magnetic field and the Martian atmosphere is much thinner than Earth’s, providing little shielding to the surface.
This environmental factor poses a challenge for future human exploration of Mars and is also important in understanding both geological and potential biological evolution on Mars. Both GCRs and SEPs interact with the atmosphere and, if energetic enough, penetrate into the Martian soil, or regolith, where they produce secondary particles that contribute to the complex radiation environment on the Martian surface, which is unlike anything on Earth.
“The RAD surface radiation data show an average GCR dose equivalent rate of 0.67 millisieverts per day from August 2012 to June 2013 on the Martian surface,” said Hassler. Radiation dose is measured in units of sievert (Sv) or millisievert (1/1000 Sv). “In comparison, RAD data show an average GCR dose equivalent rate of 1.8 millisieverts per day on the journey to Mars, when RAD measured the radiation inside the spaceship.”
According to RAD data, most mission radiation exposure will be during outbound and return travel, when the astronauts will be exposed to the radiation environment in interplanetary space, shielded only by the spacecraft itself. The total during just the transit phases of a Mars mission would be approximately 0.66 Sv for a round trip with current propulsion systems and during similar solar activity. A 500-day mission on the surface would bring the total exposure to around 1 Sv.
Long-term population studies have shown that exposure to radiation increases a person’s lifetime cancer risk; exposure to a dose of 1 Sv is associated with a five percent increase in fatal cancer risk. Although NASA has generally established a three percent increased risk of fatal cancer as an acceptable career limit for astronauts in low earth orbit, it does not currently have a limit for deep space missions, and is working with the National Academies Institute of Medicine to determine appropriate limits for deep space missions, such as a mission to Mars in the 2030s.
SwRI, together with Christian Albrechts University in Kiel, Germany, built RAD with funding from the NASA Human Exploration and Operations Mission Directorate and Germany’s national aerospace research center, Deutsches Zentrum für Luft- und Raumfahrt.
NASA’s Jet Propulsion Laboratory, a division of the California Institute of Technology, Pasadena, Calif., manages the Mars Science Laboratory Project. The NASA Science Mission Directorate, at NASA Headquarters in Washington, manages the Mars Exploration Program.
"Mars’ Surface Radiation Environment Measured with the Mars Science Laboratory’s Curiosity Rover,” published in Science online December 9, was written by Hassler, Cary Zeitlin of SwRI, Robert F. Wimmer-Schweingruber of Christian Albrechts University, Bent Ehresmann of SwRI, Scot Rafkin of SwRI, Jennifer L. Eigenbrode of NASA’s Goddard Space Flight Center, David E. Brinza of JPL, Gerald Weigle of SwRI, Stephan Böttcher of Christian Albrechts University , Eckart Böhm of Christian Albrechts University, Soenke Burmeister of Christian Albrechts University, Jingnan Guo of Christian Albrechts University, Jan Köhler of Christian Albrechts University, Cesar Martin of Christian Albrechts University, Guenther Reitz of German Aerospace Center in Cologne, Germany, Francis A. Cucinotta of University of Nevada Las Vegas, Myung-Hee Kim of Universities Space Research Association, David Grinspoon of the Denver Museum of Nature and Science, Mark A. Bullock of SwRI, Arik Posner of NASA, Javier Gómez-Elvira of Centro de Astrobiología in Madrid, Spain, Ashwin Vasavada of JPL, and John P.Grotzinger of JPL, and the MSL Science Team.
Images to accompany this story are available at: http://www.swri.org/press/2013/mars-measurements.htm.
For more information, contact Deb Schmid, (210) 522-2254, Communications Department, Southwest Research Institute, PO Drawer 28510, San Antonio, TX 78228-0510.
Deb Schmid | EurekAlert!
Upwards with the “bubble shuttle”: How sea floor microbes get involved with methane reduction in the water column
27.05.2020 | Leibniz-Institut für Ostseeforschung Warnemünde
An international team including scientists from MARUM discovered ongoing and future tropical diversity decline
26.05.2020 | MARUM - Zentrum für Marine Umweltwissenschaften an der Universität Bremen
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
27.05.2020 | Information Technology
27.05.2020 | Physics and Astronomy
27.05.2020 | Earth Sciences